Clinical Research Directory
Browse clinical research sites, groups, and studies.
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Sponsor: UroGen Pharma Ltd.
Summary
The purpose of this registry is to evaluate real world experience and outcomes of patients with Upper Tract Urothelial Cancer (UTUC) treated with Jelmyto in the United States.
Official title: uTRACT Jelmyto Registry: A Multicenter, Prospective and Retrospective Registry to Evaluate Real World Experience and Outcomes of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2023-11-17
Completion Date
2028-01
Last Updated
2025-02-28
Healthy Volunteers
No
Conditions
Interventions
Jelmyto (mitomycin) for pyelocalyceal solution
The dose of Jelmyto to be instilled is 4 mg per mL via ureteral catheter or a nephrostomy tube, with total instillation volume based on volumetric measurements using pyelography, not to exceed 15 mL (60 mg of mitomycin). Instill Jelmyto once weekly for six weeks. For patients with a complete response 3 months after Jelmyto initiation, Jelmyto instillations may be administered once a month for a maximum of 11 additional instillations.
Locations (22)
Providence St. Johns Health Center
Santa Monica, California, United States
University of Florida
Gainesville, Florida, United States
Mount Sinai Medical Center of Florida, Inc.
Miami, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc.
Tampa, Florida, United States
Northwestern University
Chicago, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
The State University of Iowa
Iowa City, Iowa, United States
Chesapeake Urology
Baltimore, Maryland, United States
Johns Hopkins Medical Center
Baltimore, Maryland, United States
Mass General Hospital (MGH)
Boston, Massachusetts, United States
The Brigham and Womens Hospital
Boston, Massachusetts, United States
University of Michigan
Ann Arbor, Michigan, United States
University of Missouri
Columbia, Missouri, United States
Rutgers
New Brunswick, New Jersey, United States
The Feinstein Institutes for Medical Research
Lake Success, New York, United States
NYU Grossman School of Medicine
New York, New York, United States
SUNY Upstate
Syracuse, New York, United States
The University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
Ohio State University
Columbus, Ohio, United States
Medical University of South Carolina
Charleston, South Carolina, United States
UT Southwestern Medical Center
Dallas, Texas, United States
The University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States